Our finding of IGF-1R upregulation in NEVs is promising because several post-mortem and epidemiological studies support the idea that upregulation of IGF signaling may protect against Alzheimer’s disease (AD). The gene discussed is IGF1; the disease is early-onset autosomal dominant Alzheimer disease.